Articles tagged with 'STEMI' | BIOTRONIK

BIOTRONIK - Archive (STEMI)

2021
20
May
2021
| 13:33 Europe/Amsterdam
More than 200 years after James Lind experimented with citrus fruits as a way to fight scurvy in sailors – in what is thought to be the world’s first clinical trial – we mark May 20 as Clinical Trials Day. On this day, we spotlight and celebrate adva...
Read more
15
March
2021
| 14:42 Europe/Amsterdam
BIOTRONIK’s ultrathin-strut stent, Orsiro®*, demonstrated superiority over Xience DES for target lesion failure (TLF) at 24 months, according to new follow-up data from the BIOSTEMI trial.1The latest results were presented by Prof. Thomas Pilgrim, In...
Read more
2019
18
October
2019
| 14:54 Europe/Amsterdam
About 30 percent of patients undergoing primary percutaneous coronary intervention (PCI) suffer from ST-Elevation Myocardial Infarction (STEMI) – the most acute form of coronary artery disease. It’s caused by a complete thrombotic occlusion and is as...
Read more
02
September
2019
| 00:00 Europe/Amsterdam
BIOTRONIK’s ultrathin Orsiro® stent demonstrated superiority over Xience with respect to target lesion failure (TLF) at 12 months, according to newly released data from the BIOSTEMI trial.1 Today Dr. Juan Fernando Iglesias, Geneva University Hospital...
Read more